Drugs in R&D logo Adis International logo

Publisher: Adis International

Related content
Volume 6, Number 5, 2005

< previous issue | all issues | next issue >

Original Research Article

Eslicarbazepine Acetate (BIA 2-093): Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations
pp. 253-260(8)
Authors: Fontes-Ribeiro, Carlos; Nunes, Teresa; Falcão, Amilcar; Neta, Carla; Lima, Ricardo; Tavares, Susana; Almeida, Luis; Macedo, Tice; Soares-da-Silva, Patricio

Colestilan, a New Bile Acid-Sequestering Resin, Reduces Bodyweight in Postmenopausal Women Who have Dieted Unsuccessfully
pp. 273-279(7)
Authors: Koike, Koji; Murakami, Kouichi; Nozaki, Noriko; Sugiura, Kouichi; Inoue, Masaki

A Randomised, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy of MF 5232 (Mucotrol™), a Concentrated Oral Gel Wafer, in the Treatment of Oral Mucositis
pp. 291-298(8)
Authors: Naidu, M.U.R.; Ramana, G. Venkat; Ratnam, S. Venkat; Sudhavani, T.; K. Jaganath Rao Naidu,; Roy, P.; Suresh, P.; Rani, P. Usha; Mohan, I. Krishna

Short Communication

Phase I Trial of Dose-Dense Docetaxel and Doxorubicin with or without Sargramostim in Patients with Metastatic Breast Cancer
pp. 299-305(7)
Authors: Montero, Alberto; Booser, Daniel; Esparza-Guerra, Laura; Murray, James; Rosales, Marguerite; Hortobagyi, Gabriel; Valero, Vicente

Adis R&D Profile

Dapoxetine: LY 210448
pp. 307-311(5)
Author: Adis International Limited,

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page